Overview
The global electroencephalography devices market reached US$ 1.48 billion in 2023 and is expected to reach US$ 3.08 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
An electroencephalogram (EEG) is a painless test that records brain activity using small sensors attached to the scalp. These signals are analyzed by a doctor, usually a clinical neurophysiologist. EEGs can help diagnose and monitor various brain conditions, such as epilepsy, which causes repeated seizures. The main use of EEGs is to detect and investigate epilepsy, helping doctors identify the type of epilepsy, triggers, and the best treatment for the patient. The procedure is usually carried out by a highly trained specialist during a hospital visit.
Executive Summary
Market Dynamics: Drivers & Restraints
Rise in the Technological Advancements
Technological advancements are one of the significant driving factors in the Global Electroencephalography (EEG) Devices Market by revolutionizing brainwave data capture, analysis, and utilization. Wireless and wearable EEG devices enhance portability and user convenience, enabling real-time monitoring in clinical and non-clinical settings. High-density EEG systems and improved sensor technology improve brain activity mapping accuracy, enabling better neurological diagnosis. The integration of AI and machine learning algorithms transforms data interpretation, enabling faster, more precise analysis for complex neurological conditions. Cloud-based data storage and IoT-enabled devices broaden EEG technology's application across telemedicine, gaming, and cognitive research.
For instance, in April 2024, Soterix Medical has launched the MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation (HD-tES) and EEG system designed for research applications in mobile and natural environments. The lightweight, wire-free system offers 33 stimulation channels and 32 recording channels, providing unparalleled precision and application-specific targeting. The system, developed in collaboration with mBrainTrain, is designed for rapid set-up and ease of use, offering the ultimate solution for mobile hybrid stimulation/EEG studies.
Lack of Skilled Professionals
The Global Electroencephalography (EEG) Devices Market faces challenges due to a shortage of skilled professionals, limiting the full utilization of advanced technologies. Accurate EEG recording and analysis require expertise in electrode placement, signal acquisition, and interpreting complex brainwave data, which is often unavailable in healthcare settings, especially in emerging markets. This shortage hampers diagnostic accuracy for neurological conditions like epilepsy and sleep disorders and affects research initiatives relying on EEG data.
For more details on this report – Request for Sample
Segment Analysis
The global electroencephalography devices market is segmented based on product type, application, technology, end user and region.
Product Type:
Portable EEG Devices segment is expected to dominate the Electroencephalography Devices market share
The portable EEG devices segment holds a major portion of the electroencephalography devices market share and is expected to continue to hold a significant portion of the electroencephalography devices market share during the forecast period.
Portable EEG devices are revolutionizing the Global Electroencephalography (EEG) Devices Market by providing accessibility and convenience in neurological diagnostics and monitoring. These devices are designed for mobility, allowing patients to undergo testing outside traditional clinical settings, particularly for conditions like epilepsy, sleep disorders, and brain injuries. Equipped with advanced wireless technologies, they enable real-time data transmission and integration with digital platforms for analysis and storage. Their compact design and user-friendly interfaces make them suitable for telemedicine applications, expanding their reach to underserved or remote areas.
For instance, in April 2024, NeuroVigil has launched its iBrain personal brain monitor in the U.S., a noninvasive device that records brain electrical activity in individuals with neurological conditions. The device, based on electroencephalogram (EEG) technology, can be used at home and during sleep for efficient and user-friendly EEG data collection. In the second phase, a smaller version will be used to detect signs of Parkinson's disease.
Application:-
The disease diagnosis segment is the fastest-growing segment in the electroencephalography devices market share and is expected to hold the market share over the forecast period.
The Global Electroencephalography (EEG) Devices Market is driven by the need for early diagnosis and monitoring of various neurological conditions. EEG devices are used for detecting epilepsy, Alzheimer's, Parkinson's, stroke, and brain tumors. They also aid in diagnosing sleep disorders like insomnia and obstructive sleep apnea by monitoring brain activity during sleep cycles. The increasing prevalence of these disorders and the focus on early detection and personalized treatment have driven the demand for advanced EEG systems, including portable and wearable devices. This underscores the crucial role of EEG in improving neurological healthcare outcomes globally.
For instance, in December 2024, LVIS Corporation has launched NeuroMatch Access, a cloud-based SaaS platform designed to streamline EEG diagnostics review and improve physician collaboration. The platform, now available in the US, enables neurologists to quickly review and interpret EEG data, enabling real-time collaboration for more accurate and timely diagnoses. NeuroMatch, a cutting-edge technology that uses artificial intelligence to remove unwanted artifacts, enables clinicians to visualize and understand brain circuit communication pathways, facilitating targeted interventions and restorative strategies to enhance neurological health.
Geographical Analysis
North America holds a substantial position in the electroencephalography devices market and is expected to hold most of the market share due to advanced healthcare infrastructure and increasing prevalence of neurological disorders like epilepsy, Alzheimer's, and Parkinson's. Demand for EEG devices is driven by high awareness of early diagnosis and treatment, company’s partnerships, government and private funding for neuroscience research, widespread adoption of advanced devices like portable and wearable EEG systems, and ongoing innovation in AI and machine learning integration.
For instance, in January 2024, Gate Neurosciences has partnered with Beacon Biosignals to advance the use of electroencephalogram (EEG) biomarkers in neuropsychiatry and cognition. The collaboration will use Beacon Biosignals' Dreem 3S headband device and neurobiomarker platform to conduct exploratory EEG and sleep analyses in depressed patients enrolled in Gate's Phase 2 trial of zelquistinel, a rapid-acting, once-weekly oral NMDA receptor positive modulator for treating major depressive disorder.
Europe is growing at the fastest pace in the Electroencephalography Devices market
Europe holds the fastest pace in the electroencephalography devices market and is expected to hold most of the market share due to a increased healthcare investments and focus on mental health and neurological research. The increasing incidence of neurodegenerative diseases and sleep disorders in the aging population necessitates advanced diagnostic tools like EEG. Government initiatives and research grants are also driving this growth. The adoption of digital health solutions and home-based and telehealth monitoring further supports the EEG market expansion.
For instance, in December 2024, Neuroelectrics and Neuronostics have partnered to offer an integrated EEG solution for pharmaceutical, contract research organisations, and academic partners. The partnership combines Neuroelectrics' advanced EEG hardware with Neuronostics' proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research. The platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are efficient and impactful. This partnership addresses the critical need for high-quality, actionable data in clinical trials.
Competitive Landscape
The major global players in the electroencephalography devices market include Natus Medical Incorporated, Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Neurosoft, Micromed Group, Cadwell Industries, Inc, Electrical Geodesics, Inc (Philips Healthcare) Brain Products GmbH, Advanced Brain Monitoring, Inc and among others.
Key Developments
- In May 2024, ChristianaCare has introduced an innovative EEG brain monitoring program, a first of its kind, which can be performed at the bedside to measure brain electrical activity, providing vital signs for brain function and enabling quicker diagnosis of seizures.
- In January 2024, Aditxt, a health innovation company, has acquired a portfolio of EEG brain monitoring technologies and devices, formerly owned by Brain Scientific. The acquisition will help shape the neurology monitoring market and shape its dynamic landscape for neurological care.
| Metrics | Details | |
| CAGR | 7.4% | |
| Market Size Available for Years | 2018-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Bn) | |
| Volume (Units) | ||
| Segments Covered | Product Type | Portable EEG Devices, Standalone EEG Devices, Wearable EEG Devices, Wireless EEG Devices |
| Application | Disease Diagnosis, Monitoring, Research | |
| Technology | Digital EEG, Analog EEG | |
| End User | Hospitals, Diagnostic Centers, Ambulatory Surgical Centers Research Institutes, Home Healthcare | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global electroencephalography devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2023
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
